• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Surveillance for Acute Flaccid Myelitis ― United States, 2018–2022

Shiloh

Editor, Senior Moderator
Source: https://www.cdc.gov/mmwr/volumes/73/wr/mm7304a1.htm?s_cid=mm7304a1_w

Surveillance for Acute Flaccid Myelitis ― United States, 2018–2022
Weekly / February 1, 2024 / 73(4);70–76

Erin R. Whitehouse, PhD1; Adriana Lopez, MHS1; Randall English, MS1,2; Halle Getachew, MPH1; Terry Fei Fan Ng, PhD1; Brian Emery1; Shannon Rogers, MS1; Sarah Kidd, MD1 (View author affiliations)

Abstract

Acute flaccid myelitis (AFM) is a serious neurologic condition primarily affecting children; AFM can cause acute respiratory failure and permanent paralysis. AFM is a rare but known complication of various viral infections, particularly those of enteroviruses (EVs). Increases in AFM cases during 2014, 2016, and 2018 were associated with EV-D68 infection. This report examines trends in confirmed AFM cases during 2018–2022 and patients’ clinical and laboratory characteristics. The number of AFM cases was low during 2019–2022 (28–47 cases per year); the number of cases remained low in 2022 despite evidence of increased EV-D68 circulation in the United States. Compared with cases during the most recent peak year (2018), fewer cases during 2019–2021 had upper limb involvement, prodromal respiratory or febrile illness, or cerebrospinal fluid pleocytosis, and more were associated with lower limb involvement. It is unclear why EV-D68 circulation in 2022 was not associated with an increase in AFM cases or when the next increase in AFM cases will occur. Nonetheless, clinicians should continue to suspect AFM in any child with acute flaccid limb weakness, especially those with a recent respiratory or febrile illness...

 
Back
Top